[ad_1] A new study has found that a new genetically engineered T cell by researchers at the University of Arizona Health Sciences is capable of targeting and attacking the pathogenic T cells that cause type 1 diabetes, which could lead to new immunotherapy treatments. The immune system fights bacteria, viruses …
Read More »Genetically engineered T cells could lead to autoimmune disease therapies – Edexlive
